RT @carpe_diem0820: COVID-19 120万人(22カ国)を54研究と2医療DBで評価 1つ以上のLong COVID症状保有率6.2% 呼吸器症状3.7%、疼痛や気分変動を伴う持続疲労3.2%、認知障害2.2% 女性>男性 Individuals Wi…
@CronhardtStacy @SeirdNavNnac @crwequine Actually, there's already some research on that - and as you probably expected, it doesn't bode well for patients. https://t.co/R8KorXs0sX
The research was published in @CellCellPress https://t.co/eTDFDTgGxa & has been covered by the New York Times, PBS News Hour, The Washington Post, and many, many other media outlets. Kudos to the research team who conducted this foundational work. @fre
RT @carpe_diem0820: COVID-19 120万人(22カ国)を54研究と2医療DBで評価 1つ以上のLong COVID症状保有率6.2% 呼吸器症状3.7%、疼痛や気分変動を伴う持続疲労3.2%、認知障害2.2% 女性>男性 Individuals Wi…
Multiple early factors anticipate post-acute COVID-19 sequelae https://t.co/pFIQhzxy5x
RT @bennosaurus: If this tweet grabs you with the "four factors" but you are stopped by the paywall... You can find the original study he…
RT @bennosaurus: If this tweet grabs you with the "four factors" but you are stopped by the paywall... You can find the original study he…
If this tweet grabs you with the "four factors" but you are stopped by the paywall... You can find the original study here: https://t.co/1sZJcrpo7j the factors = high early levels of viral RNA, certain autoantibodies, reactivation of Epstein-Barr virus
RT @carpe_diem0820: COVID-19 120万人(22カ国)を54研究と2医療DBで評価 1つ以上のLong COVID症状保有率6.2% 呼吸器症状3.7%、疼痛や気分変動を伴う持続疲労3.2%、認知障害2.2% 女性>男性 Individuals Wi…
RT @carpe_diem0820: COVID-19 120万人(22カ国)を54研究と2医療DBで評価 1つ以上のLong COVID症状保有率6.2% 呼吸器症状3.7%、疼痛や気分変動を伴う持続疲労3.2%、認知障害2.2% 女性>男性 Individuals Wi…
RT @carpe_diem0820: COVID-19 120万人(22カ国)を54研究と2医療DBで評価 1つ以上のLong COVID症状保有率6.2% 呼吸器症状3.7%、疼痛や気分変動を伴う持続疲労3.2%、認知障害2.2% 女性>男性 Individuals Wi…
RT @carpe_diem0820: COVID-19 120万人(22カ国)を54研究と2医療DBで評価 1つ以上のLong COVID症状保有率6.2% 呼吸器症状3.7%、疼痛や気分変動を伴う持続疲労3.2%、認知障害2.2% 女性>男性 Individuals Wi…
RT @carpe_diem0820: COVID-19 120万人(22カ国)を54研究と2医療DBで評価 1つ以上のLong COVID症状保有率6.2% 呼吸器症状3.7%、疼痛や気分変動を伴う持続疲労3.2%、認知障害2.2% 女性>男性 Individuals Wi…
RT @carpe_diem0820: COVID-19 120万人(22カ国)を54研究と2医療DBで評価 1つ以上のLong COVID症状保有率6.2% 呼吸器症状3.7%、疼痛や気分変動を伴う持続疲労3.2%、認知障害2.2% 女性>男性 Individuals Wi…
COVID-19 120万人(22カ国)を54研究と2医療DBで評価 1つ以上のLong COVID症状保有率6.2% 呼吸器症状3.7%、疼痛や気分変動を伴う持続疲労3.2%、認知障害2.2% 女性>男性 Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters After COVID-19 https://t.co/mJPe5WfUD5 https://t.co/4PyAUiWHPW
RT @BhupeshPrusty: Glad to see that our hypothesis on reactivation of latent herpesviruses and Post-COVID is coming true. Multiple Early Fa…
ナイーブな状態ではなく、エフェクターまたはメモリー表現型に極性化されていると仮定しています。 https://t.co/IKHkel6hUQ
RT @Aguirre1Gustavo: Study confirms that the development of #LongCOVID is associated with the level of VIRAL LOAD in blood in the acute sta…
RT @Aguirre1Gustavo: @Shaheer_Mahmood According to studies Viral Persistence is mainly associated with the level of Viral Load in the blood…
@Shaheer_Mahmood According to studies Viral Persistence is mainly associated with the level of Viral Load in the blood in the acute stage The use of drugs that are not effective against viral load such as Remdesivir,Corticosteroids can facilitate persisten
@F_Lund_Johansen @godager @Festlegen @AnnMauseth @zalaly Det er jo også flere studier som nå viser at risikoen for utvikling av long COVID er korrelert med (bl.a.) sirkulerende EBV. Spørsmålet er om vi bør se mer mot samtidige infeksjonstilstander enn vi h
RT @OMwvw: cellに掲載された論文 新型コロナと診断された309人を追跡し、マルチオミクスの観点から後遺症のリスク因子を四つに絞り込みました すなわち ・2型糖尿病の併存 ・コロナのRNAが血中に存在 ・EBウィルスが血中に存在 ・特定の自己抗体の存在 です ht…
@AGoldsmithEsq @limits_stop @alexmeshkin @WesElyMD Thinking seems to be an early spike in viral load might contribute to LC. Not sure how relevant it is to vaccines, or prior infection, but it might be. https://t.co/Wm9W2e5zSq
RT @OMwvw: cellに掲載された論文 新型コロナと診断された309人を追跡し、マルチオミクスの観点から後遺症のリスク因子を四つに絞り込みました すなわち ・2型糖尿病の併存 ・コロナのRNAが血中に存在 ・EBウィルスが血中に存在 ・特定の自己抗体の存在 です ht…
cellに掲載された論文 新型コロナと診断された309人を追跡し、マルチオミクスの観点から後遺症のリスク因子を四つに絞り込みました すなわち ・2型糖尿病の併存 ・コロナのRNAが血中に存在 ・EBウィルスが血中に存在 ・特定の自己抗体の存在 です https://t.co/sUV24URYGL https://t.co/1vCpuGugbo
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
“For those working in unsafe conditions, (here r) what sections of th Occupational Health & Safety (OHS) Act may apply. You can hilite them in an unsafe work claim readable Thread by @freespiritus Says 27/ https://t.co/HmbwQlCtEA - https://t.co/f1wd9w
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
@Veiel @Propofolium @PsychophieToBe @rogguronium @andree_dominik Auch zum Vergleich 👇🏼 https://t.co/nwT6GeI7sc
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
@Biohazard3737 Sheep, have you done any serology/blood tests to pinpoint whether you are experiencing PASC complications that are likely upstream and potentially driving these afib symptoms? https://t.co/0O2Pz0NxUb https://t.co/EzWLFMzCfu https://t.co/Ec
RT @AltGovDoc: Multiple early factors anticipate post-acute COVID-19 sequelae: Cell https://t.co/L8o3bvBcgF
RT @AltGovDoc: Multiple early factors anticipate post-acute COVID-19 sequelae: Cell https://t.co/L8o3bvBcgF
Multiple early factors anticipate post-acute COVID-19 sequelae: Cell https://t.co/L8o3bvBcgF
@StefanReich15 @Karl_Lauterbach Bilden Sie sich endlich fort. https://t.co/NHviU3MEIj
RT @keisuke4713: 複数初期要因がpost-acute COVID-19(PASC)後遺症を予測 https://t.co/kPFtFDdHrx コロナ診断時の潜伏性EBV再活性化とコロナRNA血症はPASC予測 初期に呼吸器系LC発症者cortisol⬇ 急性…
RT @carpe_diem0820: マルチオミクス評価でLong COVIDは自己抗体、ウイルス血症、併存疾患と関連 潜伏ウイルスの再活性化が関連か 不顕性自己抗体と抗SARS-CoV-2抗体は負の相関 消化器PASCは細胞傷害性 T 細胞の膨張を伴う Multiple…
マルチオミクス評価でLong COVIDは自己抗体、ウイルス血症、併存疾患と関連 潜伏ウイルスの再活性化が関連か 不顕性自己抗体と抗SARS-CoV-2抗体は負の相関 消化器PASCは細胞傷害性 T 細胞の膨張を伴う Multiple early factors anticipate post-acute COVID-19 sequelae https://t.co/asWIaSUihQ https://t.co/z5BlD6TMip
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @Marc_Veld: De aanwezigheid van een verhoogde reactie tegen herpesvirussen, die het grootste deel van ons bij zich dragen, is een bevest…
RT @keisuke4713: 複数初期要因がpost-acute COVID-19(PASC)後遺症を予測 https://t.co/kPFtFDdHrx コロナ診断時の潜伏性EBV再活性化とコロナRNA血症はPASC予測 初期に呼吸器系LC発症者cortisol⬇ 急性…
RT @keisuke4713: 複数初期要因がpost-acute COVID-19(PASC)後遺症を予測 https://t.co/kPFtFDdHrx コロナ診断時の潜伏性EBV再活性化とコロナRNA血症はPASC予測 初期に呼吸器系LC発症者cortisol⬇ 急性…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @keisuke4713: 複数初期要因がpost-acute COVID-19(PASC)後遺症を予測 https://t.co/kPFtFDdHrx コロナ診断時の潜伏性EBV再活性化とコロナRNA血症はPASC予測 初期に呼吸器系LC発症者cortisol⬇ 急性…
複数初期要因がpost-acute COVID-19(PASC)後遺症を予測 https://t.co/kPFtFDdHrx コロナ診断時の潜伏性EBV再活性化とコロナRNA血症はPASC予測 初期に呼吸器系LC発症者cortisol⬇ 急性感染1年以上経したLCのcortisol産生が 持続⬇という此迄の発見 →調査拡大すべき *慢性疲労症候群(CFS)とEBV・CMV
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
Longitudinal multi-omics associate PASC with auto-antibodies, viremia, and comorbidities Reactivation of latent viruses during initial infection may contribute to PASC Subclinical auto-antibodies negatively correlate with anti-SARS-CoV-2 antibodies http
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @manlius84: “We resolved four PASC-anticipating risk factors at the time of initial COVID-19 diagnosis: type 2 diabetes, SARS-CoV-2 RNAe…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
⑲診断時の、エプスタインバーウイルスEBVは→LongCovidコロナ後遺症の予測ウイルスの1つ
RT @KashPrime: Papers that show continuing dysfunction in T-cells: In Long Covid patients: https://t.co/xyQ5rfpXf7 In severe Covid-19 dise…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…
RT @VirusesImmunity: This again is consistent with the report by @SuYapeng et al, showing that EBV viremia at the time of diagnosis is one…